ES2107707T3 - Empleo de esteres de l-carnitina y acil l-carnitina con hidroxiacidos para produccion de composiciones farmaceuticas para el tratamiento de dermatosis. - Google Patents

Empleo de esteres de l-carnitina y acil l-carnitina con hidroxiacidos para produccion de composiciones farmaceuticas para el tratamiento de dermatosis.

Info

Publication number
ES2107707T3
ES2107707T3 ES94108921T ES94108921T ES2107707T3 ES 2107707 T3 ES2107707 T3 ES 2107707T3 ES 94108921 T ES94108921 T ES 94108921T ES 94108921 T ES94108921 T ES 94108921T ES 2107707 T3 ES2107707 T3 ES 2107707T3
Authority
ES
Spain
Prior art keywords
carnitine
acil
dermatosis
esters
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94108921T
Other languages
English (en)
Inventor
Claudio Cavazza
Paolo Cavazza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Avantgarde SpA
Original Assignee
Avantgarde SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avantgarde SpA filed Critical Avantgarde SpA
Application granted granted Critical
Publication of ES2107707T3 publication Critical patent/ES2107707T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

SE PRESENTA EL USO DE ESTERES DE L-CARNITINA Y DE ACIL L-CARNITINAS CON HIDROXIACIDOS PARA LA PRODUCCION DE COMPOSICIONES FARMACEUTICAS APTAS PARA SU ADMINISTRACION TOPICA PARA EL TRATAMIENTO DE CASOS DE DERMATOSIS TALES COMO LA ICTIOSIS Y LA PSORIASIS.
ES94108921T 1993-06-22 1994-06-10 Empleo de esteres de l-carnitina y acil l-carnitina con hidroxiacidos para produccion de composiciones farmaceuticas para el tratamiento de dermatosis. Expired - Lifetime ES2107707T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM930399A IT1261984B (it) 1993-06-22 1993-06-22 Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.

Publications (1)

Publication Number Publication Date
ES2107707T3 true ES2107707T3 (es) 1997-12-01

Family

ID=11401814

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94108921T Expired - Lifetime ES2107707T3 (es) 1993-06-22 1994-06-10 Empleo de esteres de l-carnitina y acil l-carnitina con hidroxiacidos para produccion de composiciones farmaceuticas para el tratamiento de dermatosis.

Country Status (12)

Country Link
US (1) US5627212A (es)
EP (1) EP0631779B1 (es)
JP (1) JPH0710820A (es)
KR (1) KR950000142A (es)
AT (1) ATE157003T1 (es)
CA (1) CA2125238A1 (es)
DE (1) DE69405054T2 (es)
DK (1) DK0631779T3 (es)
ES (1) ES2107707T3 (es)
GR (1) GR3024866T3 (es)
IT (1) IT1261984B (es)
ZA (1) ZA944413B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1272290B (it) * 1994-06-20 1997-06-16 Avantgarde Spa Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
US6630442B1 (en) * 1997-01-10 2003-10-07 Theodore Hersh Reparatives for chemosurgery and laser (thermal) therapy
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US6138683A (en) * 1997-09-19 2000-10-31 Thione International, Inc. Smokeless tobacco products containing antioxidants
US5922346A (en) * 1997-12-01 1999-07-13 Thione International, Inc. Antioxidant preparation
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
US5863940A (en) 1997-12-01 1999-01-26 Sigma-Tau Healthscience S.P.A. Medicament and therapeutical method for treating idiopathic asthenozoospermia
DE19806889A1 (de) * 1998-02-19 1999-08-26 Beiersdorf Ag Verwendung von Acyl-Carnitin
ES2210705T5 (es) 1998-03-19 2011-02-15 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Composición combinada que comprende una l-carnitina o una alcanoil-l-carnitina, un glucosaminoglucano y/o un constituyente del mismo.
IT1306129B1 (it) * 1999-04-13 2001-05-30 Sigma Tau Ind Farmaceuti Esteri della l-carnitina o di alcanoil l-carnitine utilizzabili comelipidi cationici per l'immissione intracellulare di composti
FI111686B (fi) * 2000-04-20 2003-09-15 Simo Rasi Kosmeettinen tai ihonhoidollinen voidekoostumus, sen valmistusmenetelmä ja käyttö
US6432424B1 (en) 2000-06-29 2002-08-13 Johnson & Johnson Consumer Companies, Inc. Cosmetic compositions containing creatine, carnitine, and/or pyruvic acid
US6372791B1 (en) 2000-06-29 2002-04-16 Johnson & Johnson Consumer Companies, Inc. Method of promoting skin cell metabolism
US6649176B1 (en) 2000-06-29 2003-11-18 Johnson & Johnson Consumer Companies, Inc. Compositions containing mineral water
US6630175B1 (en) 2000-06-29 2003-10-07 Johnson & Johnson Consumer Companies, Inc. Method of reducing eye irritation
KR20050113669A (ko) * 2003-03-28 2005-12-02 론자 인코포레이티드 피부 외용 ｌ-카르니틴 조성물
WO2009114763A2 (en) * 2008-03-13 2009-09-17 Perkinelmer Las, Inc. Enzymatic substrates for multiple detection systems
ES2336995B1 (es) 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
US9259343B2 (en) 2012-07-06 2016-02-16 Newman Technologies LLC Device for mitigating plantar fasciitis
JP6466907B2 (ja) 2013-03-15 2019-02-06 パーキンエルマー・ヘルス・サイエンシーズ・インコーポレイテッドＰｅｒｋｉｎｅｌｍｅｒ Ｈｅａｌｔｈ Ｓｃｉｅｎｃｅｓ， Ｉｎｃ． ライソゾーム病の検査に関する化合物および方法
CN116568292A (zh) * 2020-11-05 2023-08-08 莱托生物股份有限公司 用于治疗皮肤病症的新组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51148042A (en) * 1975-06-14 1976-12-18 Kanebo Ltd Skin toiletry
US4839159A (en) * 1988-02-08 1989-06-13 Topicarn, Inc. Topical L-carnitine composition
IT1238344B (it) * 1989-10-20 1993-07-13 Sigma Tau Ind Farmaceuti Estere della l-carnitina con l'acido gamma-idrossibutirrico e composizioni farmaceutiche che lo contengono per l'inibizione della degenerazione neuronale e nel trattamento del coma
FR2654619B1 (fr) * 1989-11-23 1992-01-31 Sederma Sa Utilisation en cosmetique de composes destines a optimiser la penetration des principes actifs.
FR2654618B1 (fr) * 1989-11-23 1994-04-29 Sederma Sa Utilisation en cosmetique de principes actifs destines a reguler la multiplication cellulaire.
IT1240760B (it) * 1990-02-12 1993-12-17 Sigma Tau Ind Farmaceuti Esteri di acil-l-carnitine con l'acido gamma-idrossibutirrico e composizioni farmaceutiche che li contengono per l'inibizione della degenerazione neuronale e nel trattamento del coma.
IT1240775B (it) * 1990-02-23 1993-12-17 Sigma Tau Ind Farmaceuti Esteri della l-carnitina e di acil-l-carnitine con l'acido beta-idrossibutirrico e composizioni farmaceutiche che li contengono per la inibizione della degenerazione neuronale, della proteolisi epatica e nel trattamento del coma.
IT1248321B (it) * 1991-05-15 1995-01-05 Sigma Tau Ind Farmaceuti Uso di esteri di acil l-carnitine con l'acido gamma-idrossibutirrico per produrre composizioni farmaceutiche per il trattamento di epatopatie
IT1263013B (it) * 1992-10-20 1996-07-23 Avantgarde Spa Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee.

Also Published As

Publication number Publication date
ITRM930399A1 (it) 1994-12-22
JPH0710820A (ja) 1995-01-13
US5627212A (en) 1997-05-06
CA2125238A1 (en) 1994-12-23
ATE157003T1 (de) 1997-09-15
EP0631779B1 (en) 1997-08-20
IT1261984B (it) 1996-06-11
KR950000142A (ko) 1995-01-03
ITRM930399A0 (it) 1993-06-22
DE69405054D1 (de) 1997-09-25
EP0631779A1 (en) 1995-01-04
DE69405054T2 (de) 1997-12-18
DK0631779T3 (da) 1997-09-15
ZA944413B (en) 1995-02-15
GR3024866T3 (en) 1998-01-30

Similar Documents

Publication Publication Date Title
ES2107707T3 (es) Empleo de esteres de l-carnitina y acil l-carnitina con hidroxiacidos para produccion de composiciones farmaceuticas para el tratamiento de dermatosis.
US5091171B2 (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
IT1256450B (it) Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
MX9403386A (es) Pirrolidin-3-il-alquilpiperidinas sustituidas.
ES2171543T3 (es) Composiciones administrables topicamente que contienen derivados del acido 3-benzoilfenilacetico para el tratamiento de trastornos inflamatorios oftalmicos.
ES2181993T3 (es) Composiciones para el cuidado de la piel que contienen retinol o ester de retinilo.
ES2145118T3 (es) Derivados de acidos grasos y composiciones farmaceuticas que los contienen.
SV2002000097A (es) Inhibidores de metaloproteasas ref.pcs10322/82940 /bb
ES2088655T3 (es) Esteres de l-carnitina y alcanoil l-carnitinas con acido glicolico o sus esteres y composiciones farmaceuticas que las contienen para tratar dermatosis.
UA29406C2 (uk) Складні ефіри трициклічних аміноспиртів
RU94029662A (ru) Фосфонооксиметиловые эфиры производных таксана, фармацевтическая композиция, способы лечения
PT929565E (pt) Esteres de nitrato de compostos corticoides e suas aplicacoes farmaceuticas
ES2130304T3 (es) Empleo de o-esteres de l-carnitina para el tratamiento de dermatosis.
ES2111355T3 (es) Sal de l-carnitina y composiciones cosmeticas y farmaceuticas que la contienen para el tratamiento de dermatosis.
DK0912185T3 (da) Nye farmaceutiske sammensætninger indeholdende steroidnitratesterderivater, der kan anvendes som antiinflammatoriske lægemidler
ES2104133T3 (es) Composiciones cosmeticas o farmaceuticas que contienen glicerofosfolipidos desacilados para uso topico.
ES2126674T3 (es) Empleo de o-esteres de l-carnitina con acidos aromaticos para el tratamiento de dermatosis.
IT9047669A0 (it) Esteri della l-carnitina e di acil-l-carnitine con l'acido beta-idrossibutirrico e composizioni farmaceutiche che li contengono per la inibizione della degenerazione neuronale, della proteolisi epatica e nel trattamento del coma.
MX9204613A (es) Nitratos organicos, procedimientos para su preparacion y su uso en el tratamiento de enfermedades cardiovasculares
ES2120667T3 (es) Sal de l-carnitina y composiciones cosmeticas y farmaceuticas que la contienen para tratamiento de dermatosis.
RU95113437A (ru) (h±)-сложный этиловый эфир транс-2-диметиламино-1-фенил-3-циклогексентранс-1-карбоновой кислоты в виде первичного ортофосфата и твердая фармацевтическая композиция с обезболивающей активностью
TR199900662T2 (xx) 1-Hidroksi-2-piridonlar�n seborik dermatit tedavisi amac�yla kullan�m�
ES2134184T3 (es) Empleo de etisterona para el tratamiento topico del acne o de la alopecia androgenetica.
ES2118248T3 (es) Esteres y amidas de 9-cloro-prostaglandina y su empleo para preparar medicamentos.
ATE103890T1 (de) Neue acylaminosaeurederivate enthaltende arzneimittel und diaetetika.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 631779

Country of ref document: ES